Stockscreener 앱 받기
19.21
3.71%
-0.74
전일 마감가:
$19.95
열려 있는:
$19.86
하루 거래량:
852.80K
Relative Volume:
0.45
시가총액:
$1.01B
수익:
$59,000
순이익/손실:
$-84.74M
주가수익비율:
-3.2994
EPS:
-5.8222
순현금흐름:
$-59.69M
1주 성능:
+1.96%
1개월 성능:
+46.64%
6개월 성능:
+13.33%
1년 성능:
+292.04%
1일 변동 폭
$18.42
$20.45
1주일 범위
$18.36
$20.65
52주 변동 폭
$4.61
$24.27
아발로 테라퓨틱스 Stock (AVTX) Company Profile
명칭
Avalo Therapeutics Inc
전화
410-522-8707
주소
1500 LIBERTY RIDGE DRIVE, WAYNE
Compare AVTX vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
19.21 | 1.01B | 59,000 | -84.74M | -59.69M | -5.8222 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
아발로 테라퓨틱스 Stock (AVTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-09 | 개시 | Wolfe Research | Outperform |
| 2026-04-06 | 개시 | Citizens | Mkt Outperform |
| 2026-02-02 | 개시 | Guggenheim | Buy |
| 2025-12-18 | 개시 | Mizuho | Outperform |
| 2025-09-17 | 재확인 | H.C. Wainwright | Buy |
| 2025-09-05 | 개시 | TD Cowen | Buy |
| 2025-08-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-06-02 | 재개 | H.C. Wainwright | Buy |
| 2025-03-25 | 개시 | Jefferies | Buy |
| 2025-03-25 | 개시 | Stifel | Buy |
| 2025-02-28 | 개시 | Piper Sandler | Overweight |
| 2025-02-21 | 개시 | Wedbush | Outperform |
| 2024-12-19 | 개시 | BTIG Research | Buy |
| 2024-10-24 | 개시 | H.C. Wainwright | Neutral |
| 2024-04-16 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-09-24 | 개시 | RBC Capital Mkts | Outperform |
모두보기
아발로 테라퓨틱스 주식(AVTX)의 최신 뉴스
Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum - The Manila Times
Avalo Therapeutics sets one-on-one investor meetings at Leerink Forum - Stock Titan
Millennium Group (AVTX) reports shared control of 9,857 Avalo shares (Jul 2026) - Stock Titan
AVTX Initiates Coverage by Leerink Partners -- Rating Set to Out - GuruFocus
Leerink initiates Avalo Therapeutics stock with outperform rating By Investing.com - Investing.com Australia
Leerink Partners Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $38 - Moomoo
Leerink initiates Avalo Therapeutics stock with outperform rating - Investing.com
Avalo Therapeutics CLO Paul Varki sells $1.5m shares after option exercise - Investing.com
Certain Restricted Stock Units of Avalo Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 5-JUL-2026. - marketscreener.com
Certain Options of Avalo Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 5-JUL-2026. - marketscreener.com
AVTXAvalo Therapeutics Inc Latest SEC Filings - Finviz
AVTX News | AVALO THERAPEUTICS INC (NASDAQ:AVTX) - ChartMill
Avalo Therapeutics (AVTX) director receives fully vested options grant - Stock Titan
Avalo Therapeutics (AVTX) CMO exercises options, sells 4,654 pre-planned shares - Stock Titan
Avalo Therapeutics (AVTX) director granted fully vested options on 1,080 shares - Stock Titan
Avalo Therapeutics (AVTX) director receives grant of 1,105 stock options - Stock Titan
Why Did AVTX Stock Surge 45% In Pre-Market Today? - Stocktwits
Price to earnings forward of Avalo Therapeutics, Inc. – NASDAQ:AVTX - TradingView
Enterprise value to revenue forward of Avalo Therapeutics, Inc. – NASDAQ:AVTX - TradingView
Price to sales forward of Avalo Therapeutics, Inc. – NASDAQ:AVTX - TradingView
Enterprise value to EBITDA forward of Avalo Therapeutics, Inc. – NASDAQ:AVTX - TradingView
Price to book forward of Avalo Therapeutics, Inc. – NASDAQ:AVTX - TradingView
Price to sales forward of Avalo Therapeutics Inc – LSX:A3E2FR - TradingView
Avalo Therapeutics (AVTX) Is Up 12.9% After Broad Russell Index AdditionsWhat's Changed - Yahoo Finance
Avalo Therapeutics Inc Actuals & Estimates (NASDAQ:AVTX) - TradingView
Avalo Therapeutics, Inc.(NasdaqCM:AVTX) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Avalo Therapeutics, Inc.(NasdaqCM: AVTX) added to Russell 2500 Growth Benchmark - marketscreener.com
Avalo Therapeutics, Inc.(NasdaqCM: AVTX) added to Russell 2000 Index - marketscreener.com
Avalo Therapeutics, Inc.(NasdaqCM: AVTX) added to Russell 2000 Value Benchmark - marketscreener.com
Avalo Therapeutics, Inc.(NasdaqCM: AVTX) added to Russell 2000 Growth Benchmark - marketscreener.com
Why Avalo Therapeutics (AVTX) Is Up 12.9% After Broad Russell Index Inclusion And Pipeline Progress - Sahm
Avalo Therapeutics, Inc.(NasdaqCM: AVTX) added to Russell 3000E Growth Benchmark - marketscreener.com
Avalo Therapeutics, Inc.(NasdaqCM:AVTX) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Avalo Therapeutics Edges Higher, Testing Key Resistance at $19.11MFI Oversold - dars.gov.et
Avalo Therapeutics (AVTX) Joins Russell 2000 and 3000 Indices - GuruFocus
Avalo Therapeutics added to Russell 2000 and 3000 indexes By Investing.com - Investing.com Nigeria
Avalo Therapeutics added to Russell 2000 and 3000 indexes - Investing.com
Avalo Therapeutics to Join Russell 2000, Russell 3000 Indexes - marketscreener.com
Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes - GlobeNewswire
AVTX Forecast — Price Target — Prediction for 2027 - TradingView
Avalo Therapeutics CMO Mittie Doyle sells $26,100 of shares - Investing.com UK
Avalo Therapeutics CMO Mittie Doyle sells $26,100 of shares By Investing.com - Investing.com Australia
Avalo Therapeutics Inc Actuals & Estimates (FWB:C6K0) - TradingView
Form 4 Avalo Therapeutics Inc For: 25 June By Investing.com - Investing.com Australia
Avalo Therapeutics (AVTX) CMO trades 1,450 shares in 10b5-1 exercise-and-sell - Stock Titan
Avalo Therapeutics (AVTX) director awarded 40,200 stock options at $17.83 strike - Stock Titan
[Form 3] Avalo Therapeutics, Inc. Initial Statement of Beneficial Ownership - Stock Titan
Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Doyle Mittie - Moomoo
Avalo Therapeutics Adds Independent Director Ron Philip - The Globe and Mail
Form 8K Avalo Therapeutics Inc For: 23 June By Investing.com - Investing.com Nigeria
아발로 테라퓨틱스 (AVTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.64%
자본화:
|
볼륨(24시간):